A brief introductory video explaining Micropore's unique membrane-based system

Our Unique Technology

Latest News

Read the latest news about Micropore Technologies and use the news search tool to zero in on specific dates or subject areasLatest News

Lipid Nanoparticles Development Europe Summit

8th November 2022

During October Micropore participated in the Hanson Wade Lipid Nanoparticles Development Europe Summit. Following the success of the COVID-19 vaccine, this even...

RNA Leaders USA Conference

8th November 2022

During October Micropore participated in the LSX RNA Leaders USA Congress. This event saw experts from across the world coming together to discuss the huge adv...

Taking nanopharmaceuticals from the lab to clinics

3rd October 2022

In the most recent edition of The Chemical Engineer, Amanda Jasi speaks to Camden Cutright and Nazende Günday-Türeli of Micropore about the challenges involved ...

Next Generation Cancer Vaccine Summit

12th September 2022

During August Micropore participated in the Hanson Wade Next Generation Cancer Vaccine Summit held in Boston, Massachusetts. This event, attended by experts fro...

Micropore announces launch of new integrated crossflow DOE device

29th July 2022

The AXF-Pathfinder™, which is scheduled to be available from December 2022, will be a benchtop system, based on Micropore’s well-established AXF-mini crossflow ...

Join us at the RNA Leaders USA Conference, Boston, 18th-19th October 2022

28th July 2022

Micropore is a partner for this conference and is looking forward to meeting leaders in the field of RNA to discuss how its unique technology can support the e...

Join us at the Lipid Nanoparticles Development Europe Summit in London 18th- 20th October 2022

18th July 2022

Micropore is a main sponsor of this conference dedicated to LNP formulation and process development to enable seamless scale-up, keeping GMP compliance and manu...

Join us at the Next Generation Cancer Vaccine Development Summit in Boston 16-18th August 2022

10th July 2022

Micropore will be presenting at this event uniting senior scientists and oncology specialists who are committed to finding better antigens, more effective vecto...

Efficient scale-up is the key to efficient commercial formulation

14th June 2022

At a recent Lipid Nanoparticle (LNP) formulation and process development summit held in Boston a delegate observed that “utilising mRNA loaded LNPs is probably ...

Manufacturing Chemist LIVE 2022 review

31st May 2022

Reporting from a front row seat at the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and exciting in th...

LNP Formulation & Process Development Summit in Boston

29th April 2022

During April Micropore was delighted to contribute to the global pharmaceutical industry’s first forum dedicated to bringing together drug developers within the...

Micropore gets a specific reference in Boris Johnson's announcement of £1bn of new commercial deals with India

21st April 2022

As the UK Prime Minister, Boris Johnson's visit to India gets underway it is great to see Micropore’s mention in the accompanying press release.

Need a formulation challenge solved? Ask a Micropore expert

At Micropore we enjoy working in partnership with our clients to solve formulation challenges and deliver the highest performing, most sustainable, most cost-effective formulated delivery systems.

Ask an expert

Stay Informed

Keep up to date with innovations at Micropore. Sign up today to stay informed with innovations at Micropore and automatically receive the Micropore newsletter and webinar invites.

Alternatively, you can download the latest edition of the Micropore newsletter HERE.